(LTC) LTC Properties - Ratings and Ratios
Senior Housing, Skilled Nursing, Assisted Living
LTC EPS (Earnings per Share)
LTC Revenue
Description: LTC LTC Properties
LTC Properties Inc is a US-based Health Care REIT, a type of real estate investment trust that focuses on healthcare-related properties. REITs are known for their ability to provide stable income streams through rental income and are required to distribute a significant portion of their income to shareholders.
The companys financial health can be evaluated through key performance indicators such as Funds From Operations (FFO) and Adjusted Funds From Operations (AFFO), which are crucial metrics for REITs. A stable or growing FFO and AFFO would indicate a strong ability to generate cash and pay dividends. The Price-to-FFO ratio, not directly provided, is another important metric that can help assess the stocks valuation relative to its peers.
Key economic drivers for LTC Properties include the demand for healthcare facilities, demographic trends such as an aging population, and the overall economic conditions affecting the healthcare industry. The companys portfolio composition, including the types of healthcare facilities it owns (e.g., skilled nursing facilities, assisted living facilities), and its geographic diversification, are also critical factors influencing its financial performance.
The valuation of LTC Properties, as reflected in its P/E ratio of 19.80 and forward P/E of 12.45, suggests that the market expects a certain level of earnings growth. The Return on Equity (RoE) of 8.68% indicates the companys ability to generate profits from shareholders equity. Comparing these metrics to industry averages and the companys historical performance can provide insights into its relative attractiveness and operational efficiency.
The healthcare REIT sector is subject to various market and regulatory risks, including changes in healthcare policies, reimbursement rates, and demographic trends. LTC Properties performance is also influenced by its managements ability to navigate these challenges and capitalize on opportunities through strategic investments and operational improvements.
LTC Stock Overview
| Market Cap in USD | 1,686m |
| Sub-Industry | Health Care REITs |
| IPO / Inception | 1992-08-17 |
LTC Stock Ratings
| Growth Rating | 25.3% |
| Fundamental | 80.0% |
| Dividend Rating | 62.0% |
| Return 12m vs S&P 500 | -14.2% |
| Analyst Rating | 3.25 of 5 |
LTC Dividends
| Dividend Yield 12m | 7.04% |
| Yield on Cost 5y | 9.74% |
| Annual Growth 5y | 0.00% |
| Payout Consistency | 91.3% |
| Payout Ratio | 37.6% |
LTC Growth Ratios
| Growth Correlation 3m | 79.3% |
| Growth Correlation 12m | 26.7% |
| Growth Correlation 5y | 58.5% |
| CAGR 5y | 2.43% |
| CAGR/Max DD 3y | 0.12 |
| CAGR/Mean DD 3y | 0.28 |
| Sharpe Ratio 12m | 0.88 |
| Alpha | 0.04 |
| Beta | 0.764 |
| Volatility | 19.51% |
| Current Volume | 305.6k |
| Average Volume 20d | 282.2k |
| Stop Loss | 34.4 (-3.2%) |
| Signal | -0.33 |
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (83.1m TTM) > 0 and > 6% of Revenue (6% = 13.1m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA 1.34pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 349.8% (prev 282.2%; Δ 67.61pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 126.7m > Net Income 83.1m (YES >=105%, WARN >=100%) |
| Net Debt (589.0m) to EBITDA (159.1m) ratio: 3.70 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.28 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (46.0m) change vs 12m ago 5.90% (target <= -2.0% for YES) |
| Gross Margin 92.60% (prev 93.32%; Δ -0.73pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 11.81% (prev 10.63%; Δ 1.18pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.83 (EBITDA TTM 159.1m / Interest Expense TTM 34.3m) >= 6 (WARN >= 3) |
Altman Z'' 2.80
| (A) 0.42 = (Total Current Assets 1.36b - Total Current Liabilities 596.6m) / Total Assets 1.80b |
| (B) -0.08 = Retained Earnings (Balance) -144.2m / Total Assets 1.80b |
| (C) 0.07 = EBIT TTM 131.5m / Avg Total Assets 1.84b |
| (D) -0.19 = Book Value of Equity -141.5m / Total Liabilities 750.5m |
| Total Rating: 2.80 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 80.04
| 1. Piotroski 4.50pt = -0.50 |
| 2. FCF Yield 7.00% = 3.50 |
| 3. FCF Margin 57.74% = 7.50 |
| 4. Debt/Equity 1.07 = 1.96 |
| 5. Debt/Ebitda 6.44 = -2.50 |
| 6. ROIC - WACC (= 30.05)% = 12.50 |
| 7. RoE 8.68% = 0.72 |
| 8. Rev. Trend 78.20% = 5.86 |
| 9. EPS Trend 19.94% = 1.00 |
What is the price of LTC shares?
Over the past week, the price has changed by -2.76%, over one month by +0.61%, over three months by +2.98% and over the past year by +1.68%.
Is LTC Properties a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LTC is around 34.38 USD . This means that LTC is currently overvalued and has a potential downside of -3.26%.
Is LTC a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 5
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the LTC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 37.8 | 6.4% |
| Analysts Target Price | 37.8 | 6.4% |
| ValueRay Target Price | 38.4 | 8.2% |
Last update: 2025-09-09 04:41
LTC Fundamental Data Overview
CCE Cash And Equivalents = 915.5m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 20.2265
P/E Forward = 12.4533
P/S = 7.9103
P/B = 1.7618
P/EG = 5.41
Beta = 0.689
Revenue TTM = 217.6m USD
EBIT TTM = 131.5m USD
EBITDA TTM = 159.1m USD
Long Term Debt = 428.0m USD (from longTermDebt, last quarter)
Short Term Debt = 596.6m USD (from shortTermDebt, last quarter)
Debt = 1.02b USD (Calculated: Short Term 596.6m + Long Term 428.0m)
Net Debt = 589.0m USD (from netDebt column, last quarter)
Enterprise Value = 1.80b USD (1.69b + Debt 1.02b - CCE 915.5m)
Interest Coverage Ratio = 3.83 (Ebit TTM 131.5m / Interest Expense TTM 34.3m)
FCF Yield = 7.00% (FCF TTM 125.7m / Enterprise Value 1.80b)
FCF Margin = 57.74% (FCF TTM 125.7m / Revenue TTM 217.6m)
Net Margin = 38.17% (Net Income TTM 83.1m / Revenue TTM 217.6m)
Gross Margin = 92.60% ((Revenue TTM 217.6m - Cost of Revenue TTM 16.1m) / Revenue TTM)
Tobins Q-Ratio = -12.69 (set to none) (Enterprise Value 1.80b / Book Value Of Equity -141.5m)
Interest Expense / Debt = 0.78% (Interest Expense 8.01m / Debt 1.02b)
Taxrate = -4.05% (set to none) (-3.84m / 94.9m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 2.28 (Total Current Assets 1.36b / Total Current Liabilities 596.6m)
Debt / Equity = 1.07 (Debt 1.02b / last Quarter total Stockholder Equity 957.5m)
Debt / EBITDA = 6.44 (Net Debt 589.0m / EBITDA 159.1m)
Debt / FCF = 8.15 (Debt 1.02b / FCF TTM 125.7m)
Total Stockholder Equity = 957.0m (last 4 quarters mean)
RoA = 4.63% (Net Income 83.1m, Total Assets 1.80b )
RoE = 8.68% (Net Income TTM 83.1m / Total Stockholder Equity 957.0m)
RoCE = 9.49% (Ebit 131.5m / (Equity 957.0m + L.T.Debt 428.0m))
RoIC = 30.05% (Ebit 131.5m / (Assets 1.80b - Current Assets 1.36b))
WACC = unknown (E(1.69b)/V(2.71b) * Re(8.83%)) + (D(1.02b)/V(2.71b) * Rd(0.78%) * (1-Tc(none)))
Shares Correlation 3-Years: 96.97 | Cagr: 1.16%
Discount Rate = 8.83% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 78.13% ; FCFE base≈118.2m ; Y1≈138.4m ; Y5≈209.5m
Fair Price DCF = 67.35 (DCF Value 3.10b / Shares Outstanding 46.1m; 5y FCF grow 18.21% → 3.0% )
EPS Correlation: 19.94 | EPS CAGR: 14.38% | SUE: 0.31 | # QB: 0
Revenue Correlation: 78.20 | Revenue CAGR: 12.57% | SUE: 4.0 | # QB: 1
Additional Sources for LTC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle